News

Alstom's Q1 2025/26 Report: Growth and Strong Outlook Ahead

Alstom's Q1 2025/26 Report: Growth and Strong Outlook Ahead

Alstom's Q1 2025/26 Report: Strong Sales and Order Growth

As Alstom S.A navigates the current market landscape, it has successfully kicked off its fiscal year 2025/26 with notable results. The company has reported remarkable figures for the first quarter of this fiscal year, indicating consistent momentum. Order intake has reached €4.1 billion, a significant achievement, with a rolling stock book-to-bill ratio settling at 1.0x.

Sales Performance in Detail

Alstom's sales for the quarter amounted to €4.5 billion, marking an increase of 2.8% compared to the previous year, with an impressive 7.2% of this growth being organic. The performance is particularly commendable considering external factors, including a 2.7% headwind from foreign exchange fluctuations due to the strengthening euro.

Future Outlook Remains Positive

The positive trajectory set in Q1 establishes a solid foundation for growth in the remainder of the fiscal year. With a backlog totaling €92.3 billion as of June 30, 2025, Alstom's visibility for future sales remains robust. The company is confident in its fiscal year outlook, maintaining its medium-term ambitions intact.

Key Financial Figures

Highlighting key performance metrics: orders received for the quarter stood at 4,075 million euros compared to 3,645 million euros in Q1 of the prior fiscal year, showing an uplift of 11.8%. Sales figures for the quarter also reflect growth, indicating a general positive trend in both orders and sales.

Regional Contributions and Major Contracts

Across various regions, Europe has played a vital role in Alstom's success, contributing 85% of total order intake during this quarter. Key contracts include a significant order from SNCF Voyageurs worth around €1.7 billion for additional trainsets, along with substantial contracts in Bulgaria for electric trains valued at €720 million.

Updates on Deliveries and New Projects

The first quarter has also seen Alstom deliver significant milestones across its project portfolio. Deliveries of metro trains in France and new fleets in the UK underline Alstom's commitment to enhancing urban mobility and rail networks.

Market Stability and Operational Assumptions

Looking ahead, Alstom is cautiously optimistic about the market conditions, forecasting organic growth in sales between 3% and 5%. The company aims to maintain a book-to-bill ratio above 1.0x while generating €200 to €400 million in free cash flow.

Frequently Asked Questions

What were Alstom's key financial metrics for Q1 2025/26?

Alstom reported order intake of €4.1 billion and sales of €4.5 billion, up 2.8% from the previous year, with significant organic growth.

What does Alstom's backlog signify?

The backlog of €92.3 billion suggests strong visibility and support for future revenue growth.

Which regions contributed most to Alstom's growth during Q1?

Europe accounted for 85% of the total order intake, notably enhancing Alstom’s overall performance.

What are Alstom's sales growth expectations for the fiscal year?

The company expects organic sales growth between 3% and 5%, showcasing optimism about their market position.

What projects has Alstom recently delivered?

Key projects delivered include metro trains in France and new fleets in the UK, emphasizing Alstom's commitment to urban mobility solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 144

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 242

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Franklin Universal Trust Distributions Explained: A Deep Dive

Updated Category News Views 225

Understanding Franklin Universal Trust's Distribution Sources In the investment landscape, knowing the sources of distributions can significantly inform investors about the health of their investments. Franklin Universal Trust (NYSE: FT) recently provided an update on its distribution sources, which is vital for shareholders seeking to gauge the Fund’s performance....

Continue Reading
Bitcoin Flat, Ethereum Up: Is This Your Accumulation Moment?

Updated Category News Views 149

Bitcoin's been stuck in neutral territory lately, trading flat as of Monday with a mild dip in volatility due to holiday-driven thin liquidity. It pushed up to $70,060 but faced serious resistance, retreating back into the $68,000 zone where it seems to be camping out. Volume? Yeah, that dropped a cool 17% from yesterday's action—so you know how traders get restless...

Continue Reading
Automotive Wiper Blade Market Set for Robust Expansion

Updated Category News Views 121

Anticipated Growth in the Automotive Wiper Blade Market The global automotive wiper blade market is poised for significant growth in the coming years. Projections estimate that the market value will climb to USD 11.5 billion by 2034, up from USD 6 billion in 2024. This increase signifies a compound annual growth rate (CAGR) of 6.8%. Key drivers of this growth include...

Continue Reading
Celebrated Financial Advisor Joins Ameriprise, Enhancing Services

Updated Category News Views 190

Gary Presslaff Joins Ameriprise Financial Team In a significant move for the financial services landscape, mentor Gary Presslaff has officially joined the ranks of Ameriprise Financial, Inc. (NYSE: AMP). With four decades of industry experience, Presslaff brings a wealth of knowledge and expertise, bolstering the team at Monumental Financial Planning located in Washington...

Continue Reading
Royal Mint Celebrates Iconic Metal Band with Special Coin

Updated Category News Views 237

Royal Mint Commemorative Coin for Iron Maiden's 50th Anniversary The Royal Mint has recently unveiled an impressive commemorative coin that celebrates the remarkable 50-year journey of the legendary heavy metal band, Iron Maiden. This special release is part of The Royal Mint's Music Legends series, which has previously honored iconic musicians such as Queen, Elton John,...

Continue Reading